HPV Vaccine Advocacy Resources
Global Priorities and Needs for HPV Vaccine Advocacy
IVAC conducted an online survey with approximately 100 global stakeholders to explore which topics, audiences, and approaches may be most important to inform future HPV vaccine advocacy. To advance the shared goal of accelerating cervical cancer elimination around the world, our findings about HPV vaccine advocacy are presented in a brief report.
Suggested citation: International Vaccine Access Center (IVAC), Understanding Priorities and Needs for HPV Vaccine Advocacy: Findings from a Global Survey, IVAC at the Johns Hopkins Bloomberg School of Public Health, Baltimore, May 2023.
Country Toolkits and Case Studies
We also conducted a series of key informant interviews in two countries, Ghana and Indonesia, to better understand advocacy needs in these contexts. We created country-specific reports and toolkits based on our findings that can be used by in-country partners to advocate for HPV vaccine introduction.
Human papillomavirus (HPV)
Victoria Chou, firstname.lastname@example.org